These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2864532)

  • 1. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C; Riis BJ; Nilas L; Rødbro P; Deftos L
    Lancet; 1985 Oct; 2(8459):800-1. PubMed ID: 2864532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestagen plus cyclical oestrogen for postmenopausal bone loss.
    Selby PL; Peacock M
    Lancet; 1985 Nov; 2(8465):1194-5. PubMed ID: 2865655
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen/progestagen for postmenopausal osteoporosis.
    Stevenson JC; Whitehead MI
    Lancet; 1981 Jul; 2(8238):156. PubMed ID: 6113518
    [No Abstract]   [Full Text] [Related]  

  • 6. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women.
    Thomsen K; Riis B; Christiansen C
    J Bone Miner Res; 1986 Dec; 1(6):503-7. PubMed ID: 3332556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sex hormones on bone in primary osteoporosis.
    Riggs BL; Jowsey J; Kelly PJ; Jones JD; Maher FT
    J Clin Invest; 1969 Jun; 48(6):1065-72. PubMed ID: 5771187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Acta Med Scand; 1985; 218(3):329-33. PubMed ID: 3907290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
    Lindsay R; Hart DM; Purdie D; Ferguson MM; Clark AS; Kraszewski A
    Clin Sci Mol Med; 1978 Feb; 54(2):193-5. PubMed ID: 340117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.
    Selby PL; Peacock M
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):543-7. PubMed ID: 3113780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estradiol in the treatment of postmenopausal bone loss.
    Adami S; Suppi R; Bertoldo F; Rossini M; Residori M; Maresca V; Lo Cascio V
    Bone Miner; 1989 Aug; 7(1):79-86. PubMed ID: 2670019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.